Literature DB >> 18805414

Enhanced glycolysis induced by mtDNA mutations does not regulate metastasis.

Kaori Ishikawa1, Osamu Hashizume, Nobuko Koshikawa, Sayaka Fukuda, Kazuto Nakada, Keizo Takenaga, Jun-Ichi Hayashi.   

Abstract

We addressed the issue of whether enhanced glycolysis caused by mtDNA mutations independently induces metastasis in tumor cells using mtDNA transfer technology. The resultant trans-mitochondrial cybrids sharing the same nuclear background of poorly metastatic carcinoma P29 cells, P29mtA11 and P29mtDelta cybrids, possessed mtDNA with a G13997A mutation from highly metastatic carcinoma A11 cells and mtDNA with a 4696bp deletion mutation, respectively. The P29mtDelta cybrids expressed enhanced glycolysis, but did not express ROS overproduction and high metastatic potential, whereas P29mtA11 cybrids showed enhanced glycolysis, ROS overproduction, and high metastatic potential. Thus, enhanced glycolysis alone does not induce metastasis in the cybrids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805414     DOI: 10.1016/j.febslet.2008.09.024

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  24 in total

Review 1.  Mitochondrial Diseases Part I: mouse models of OXPHOS deficiencies caused by defects in respiratory complex subunits or assembly factors.

Authors:  Alessandra Torraco; Susana Peralta; Luisa Iommarini; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-02-04       Impact factor: 4.160

Review 2.  Homeostasis of redox status derived from glucose metabolic pathway could be the key to understanding the Warburg effect.

Authors:  Shiwu Zhang; Chuanwei Yang; Zhenduo Yang; Dan Zhang; Xiaoping Ma; Gordon Mills; Zesheng Liu
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

Review 3.  From discovery of the CHOP axis and targeting ClpP to the identification of additional axes of the UPRmt driven by the estrogen receptor and SIRT3.

Authors:  Timothy C Kenny; Doris Germain
Journal:  J Bioenerg Biomembr       Date:  2017-08-10       Impact factor: 2.945

4.  Metastasis suppressor KISS1 seems to reverse the Warburg effect by enhancing mitochondrial biogenesis.

Authors:  Wen Liu; Benjamin H Beck; Kedar S Vaidya; Kevin T Nash; Kyle P Feeley; Scott W Ballinger; Keke M Pounds; Warren L Denning; Anne R Diers; Aimee Landar; Animesh Dhar; Tomoo Iwakuma; Danny R Welch
Journal:  Cancer Res       Date:  2013-12-18       Impact factor: 12.701

Review 5.  The awakening of an advanced malignant cancer: an insult to the mitochondrial genome.

Authors:  Cody C Cook; Masahiro Higuchi
Journal:  Biochim Biophys Acta       Date:  2011-09-02

Review 6.  Homeostasis of redox status derived from glucose metabolic pathway could be the key to understanding the Warburg effect.

Authors:  Shiwu Zhang; Chuanwei Yang; Zhenduo Yang; Dan Zhang; Xiaoping Ma; Gordon Mills; Zesheng Liu
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

7.  Specific mitochondrial DNA mutation in mice regulates diabetes and lymphoma development.

Authors:  Osamu Hashizume; Akinori Shimizu; Mutsumi Yokota; Atsuko Sugiyama; Kazuto Nakada; Hiroyuki Miyoshi; Makiko Itami; Miki Ohira; Hiroki Nagase; Keizo Takenaga; Jun-Ichi Hayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

Review 8.  Regulation of metastasis; mitochondrial DNA mutations have appeared on stage.

Authors:  Kaori Ishikawa; Hirotake Imanishi; Keizo Takenaga; Jun-Ichi Hayashi
Journal:  J Bioenerg Biomembr       Date:  2012-12       Impact factor: 2.945

9.  The innate immune system in host mice targets cells with allogenic mitochondrial DNA.

Authors:  Kaori Ishikawa; Noriko Toyama-Sorimachi; Kazuto Nakada; Mami Morimoto; Hirotake Imanishi; Mariko Yoshizaki; Shigemi Sasawatari; Mamoru Niikura; Keizo Takenaga; Hiromichi Yonekawa; Jun-Ichi Hayashi
Journal:  J Exp Med       Date:  2010-10-11       Impact factor: 14.307

10.  Trading mtDNA uncovers its role in metastasis.

Authors:  Kaori Ishikawa; Jun-Ichi Hayashi
Journal:  Cell Adh Migr       Date:  2009-01-21       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.